Literature DB >> 31882166

Laryngeal Disease in Dogs and Cats: An Update.

Catriona M MacPhail1.   

Abstract

Laryngeal diseases are manifested by obstructive breathing patterns reflecting functional or mechanical upper airway obstruction. Laryngeal paralysis is the most common disease of the larynx. Diagnosis requires close attention to anesthetic plane and coordination of respiratory effort with laryngeal motion. Surgical arytenoid lateralization improves clinical signs and quality of life in dogs; however, aspiration pneumonia is a recognized complication, and generalized neuropathy can progress. Laryngeal collapse can result from any cause of chronic upper airway obstruction but is most often associated with brachycephalic obstructive airway syndrome. Although uncommon, laryngeal neoplasia has a guarded to grave prognosis regardless of treatment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aspiration pneumonia; Brachycephalic syndrome; Laryngeal collapse; Laryngeal neoplasia; Laryngeal paralysis; Megaesophagus; Upper airway obstruction

Mesh:

Year:  2019        PMID: 31882166     DOI: 10.1016/j.cvsm.2019.11.001

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  3 in total

1.  Silicone stenting as an emergency option for treatment of canine laryngeal paralysis.

Authors:  Soon-Wuk Jeong
Journal:  J Vet Sci       Date:  2022-07       Impact factor: 1.603

2.  Case Studies of Severe Microfilaremia in Four Dogs Naturally Infected With Dirofilaria repens as the Primary Disease or a Disease Complicating Factor.

Authors:  Magdalena E Wysmołek; Maciej Klockiewicz; Małgorzata Sobczak-Filipiak; Ewa Długosz; Marcin Wiśniewski
Journal:  Front Vet Sci       Date:  2020-09-22

3.  Facial conformation characteristics in Persian and Exotic Shorthair cats.

Authors:  Kerstin L Anagrius; Maria Dimopoulou; Anna N Moe; Ann Petterson; Ingrid Ljungvall
Journal:  J Feline Med Surg       Date:  2021-03-03       Impact factor: 2.015

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.